Internal Medicine, Cardiovascular Disease · Flushing, NY
NPI
1306845987
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
142-42 Booth Memorial Avenue
Flushing, NY, 11355
Phone (718) 353-4004
Groups this clinician bills Medicare through
Medicare paid, 2024
$171K
2,709 services
Medicare patients, 2024
729
Average age 77
Drug cost, 2024
$1.6M
7,752 prescriptions
Company payments, 2025
$122
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph Wiesel was code 99214 (office e&m - established), 1,063 times for 467 patients. In total Joseph Wiesel billed 2,709 services in 37 codes, and Medicare paid $171K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,063 | 467 | $102.55 | $109K |
| 93000 Electrocardiogram | Office | 922 | 489 | $12.15 | $11K |
| 93224 Electrocardiogram | Office | 149 | 145 | $58.29 | $8,685 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 88 | 22 | $5.82 | $512 |
| 99204 Office E&M - New | Office | 78 | 78 | $133.93 | $10K |
| 36415 Venipuncture Blood Collection | Office | 75 | 63 | $8.65 | $649 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 72 | 36 | $89.96 | $6,477 |
| 93015 Electrocardiogram | Office | 38 | 38 | $53.94 | $2,050 |
| 78452 Myocardial Perfusion Scan | Office | 36 | 36 | $384.64 | $14K |
| 93280 External Electrocardiographic Monitoring | Office | 22 | 18 | $58.46 | $1,286 |
| J0280 Injection, aminophyllin, up to 250 mg | Office | 18 | 18 | $6.41 | $115 |
| 93244 Electrocardiogram | Office | 14 | 14 | $19.86 | $278 |
| 93284 External Electrocardiographic Monitoring | Office | 13 | 11 | $87.44 | $1,137 |
| 93242 Electrocardiogram | Office | 12 | 12 | $11.44 | $137 |
| G0008 Administration of influenza virus vaccine | Office | 12 | 12 | $36.59 | $439 |
By year: 2022 $212K for 2,918 services; 2023 $200K for 2,910 services; 2024 $171K for 2,709 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 75 | 63 | $8.65 | $649 |
Medicare prescription drug claims, 2024
In 2024, the drug Joseph Wiesel prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,182 prescriptions and refills. In total Joseph Wiesel wrote 7,752 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,182 | 3,368 | 396 | $14K |
| Amlodipine Besylate Generic | 821 | 2,307 | 264 | $5,486 |
| Metoprolol Succinate Generic | 595 | 1,723 | 200 | $11K |
| Losartan Potassium Generic | 496 | 1,412 | 158 | $5,508 |
| Ezetimibe Generic | 441 | 1,216 | 139 | $9,516 |
| Rosuvastatin Calcium Generic | 323 | 885 | 105 | $4,806 |
| Eliquis Apixaban | 313 | 728 | 93 | $419K |
| Colchicine Generic | 298 | 773 | 105 | $24K |
| Jardiance Empagliflozin | 234 | 507 | 71 | $291K |
| Spironolactone Generic | 223 | 559 | 75 | $1,953 |
| Chlorthalidone Generic | 201 | 555 | 69 | $4,497 |
| Clopidogrel Clopidogrel Bisulfate | 199 | 580 | 64 | $2,500 |
| Furosemide Generic | 170 | 424 | 59 | $796 |
| Ramipril Generic | 154 | 454 | 49 | $1,774 |
| Metoprolol Tartrate Generic | 146 | 378 | 41 | $814 |
Brand drugs: 1,216 claims; generic drugs: 6,536 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph Wiesel $122 ($122 in general payments such as food, travel and fees) from 1 company. The largest payer was Medtronic, Inc. with $122.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 1 | $122 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.